Utah Medical Products' stock decline is overblown, as margins remain intact and the balance sheet has substantial assets.

Explore VERV's promising gene-editing therapies, including VERVE-102 with a 69% LDL-C reduction. Click here to read my most ...

Discover investment opportunities amid market uncertainty with a basket of recently selected stocks based on technical ...

FS KKR Capital's stock is undervalued, trading at a 21% discount to NAV, presenting a compelling buying opportunity despite ...

GXO Logistics faces macroeconomic pressures, integration challenges and soft 2025 growth. Read more about the company's ...

MSTY is a single stock covered call ETF tied to Strategy, which is heavily linked to Bitcoin. Find out why I'm bearish on the ...

Nvidia Corp. faces challenges, with new U.S. licensing rules cutting $5.5B from quarterly sales and China's demand declining.

Republic Services outperforms with recession-resistant cash flows, strategic investments, and robust growth. Read more about ...

Discover how we navigated surprises in Q1, updated our portfolio strategy, and reviewed performance, including insights on ...

Innovation is transforming financial markets in ways investors are only beginning to recognize amidst the breakneck pace of ...

Discover why Bitcoin acts as a hedge against currency volatility and fiscal stimulus, with bullish trends pointing to a ...

Everest Group stock appears undervalued at $350, with potential earnings per share of $40-$50. Read more to see why I'm ...